Most of the big companies that develop varieties now have an agreement amongst themselves that they won't commercialize a variety until they have the approval of seven markets: Canada, the States, Europe, Australia, and some of the key trading partners in Asia: China, India, and Japan. They've got an agreement amongst themselves that they won't put a product on the market that has not been accepted for regulatory approval into any of those markets.
I think when we talk about trade amongst the OECD countries, it may not be approved in our country, but we have a very high level of trust in the regulatory system of those countries. Where it gets to be a challenge is in countries that may have less rigorous regulatory systems or systems that are known to be corrupt in some cases. That's where a lot of thought and consideration has to come from as to how to deal with those types of products.